find your perfect postgrad program
Search our Database of 30,000 Courses

London Metropolitan University: Cancer Immunotherapy

Institution London Metropolitan University View institution profile
Department School of Human Sciences
Web https://www.londonmet.ac.uk
Email courseenquiries@londonmet.ac.uk
Telephone 020 7133 4202
Study type Taught

Summary

Why study this course?

Our Cancer Immunotherapy master's will teach you about conventional cancer therapies including surgery, radiation and chemotherapy. You’ll have access to highly qualified researchers and teachers in pharmacology and immunology, as well as those from our Cellular and Molecular Immunology Research Centre. We’ll encourage you to join professional societies so you can improve your CV and build upon the impressive skills you’ll already have developed from research projects on the course. By the end of this postgraduate course, you’ll come to understand why investigators and oncologists now believe immunotherapy combined with pharmacological treatments will soon provide curative therapies that can give patients a new lease of life.

More about this course

The Cancer Immunotherapy MSc will introduce you to the advancement of treatments that are fighting to prolong the lives of cancer patients. Cancer is increasing worldwide, and by 2030 there are expected to be 22 million new cases per year. By the end of this course, you’ll be ready for employment as a professional who can help to tackle this global challenge.

We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, as well as the current evolution of drug therapies. This will help you review the biology of cancer, taking pathological considerations into account, and the molecular changes within cells which are associated with the progression of the disease.

You’ll enhance your intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data. This means you’ll cover new areas in immunotherapy as well as existing pharmacological therapies including (but not limited to) monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; adoptive T cell therapy; dendritic cell vaccines; microbial causes of cancer; adjuvant development for vaccines; epigenetics and cancer; immuno-chemotherapy; dendritic cell vaccine development; the ageing immune system and immunotherapy; natural killer cells/tumour-associated macrophages and cancer immunotherapy and Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis.

The teaching is delivered by highly-qualified researchers and teachers in pharmacology and immunology, including those from our Cellular and Molecular Immunology Research Centre. Skills gained from research projects will be highly marketable in industry, academia and the National Health Service (NHS), and you’ll also be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

MSc

About London Met

Whether you’re looking to improve your job prospects, pursue a passion or take your career in a whole new direction, find your postgraduate degree and join London Met’s real London community today. This is the real London.

Based in one of the world's most exciting capital cities, London Metropolitan University is home to an inclusive community of inspiring and determined learners, teachers and innovative thinkers.

 By putting the emphasis on work-related learning, London Met’s courses are designed to ensure you’ll have the knowledge and skills needed for a successful career.

London Met is comprised of six …

View Profile

Not what you are looking for?

Browse other courses in Cancer nursing or Science, or search our comprehensive database of postgrad programs.

Postgraduate Bursary Opportunity with Postgrad.com

Are you studying as a PG student at the moment or have you recently been accepted on a postgraduate program? Apply now for one of our £2000 PGS bursaries.

Click here